RESEARCH TRIANGLE PARK, N.C., March 31, 2023 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (FRX:CA), a commercial stage specialty pharmaceutical company, today announced that the Committee for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback